ClickZ, they report changes that could soon be coming to Facebook that would not allow companies to disable the “Comment” feature on pages. While this is just a rumor, should it be true, Pharma marketers would face high regulatory scrutiny from the FDA, even though they still haven’t set guidelines for the use of social media mediums like this one.
The main point of concern in the article is the possibility that the Facebook users will post adverse affects of the drugs, which are then required to be reported to the FDA. Would this be your main concern for Facebook pages promoting your Pharma products? Would this hinder Pharma’s marketing advances into social media platforms?
ePharma West offers sessions led by regulatory experts to help you deal with the ever evolving world of social media. Lucy Rose of Lucy Rose & Associates and Peter Pitts of Porter Novelli will share their experiences with the FDA to give you a preview of what you can expect when regulations are actually released. You can also hear from Dr. James Fowler, author of “Connected,” as he discusses the impact of social networks, like Facebook, and the influence they have on ourhealth, tastes, happiness, and even weight. Join us July 25-27th to hear these topics and more at ePharma West. Mention the code XP1656BLOG when registering to save 10%.